You are here: Industry Insights > BioCentriq

News List

CaroGen, BioCentriq Enter Clinical Manufacturing Pact contractpharma
June 23, 2021
BioCentriq to provide clinical manufacturing to support Phase 1 clinical trials of CaroGen's lead immunotherapy candidate, CARG-201.
BioCentriq, Kytopen Enter Cell Therapy Alliance contractpharma
March 25, 2021
BioCentriq, the New Jersey Innovation Institute’s cell and gene therapy development and manufacturing center, is partnering with Kytopen, a Cambridge-based startup spun out of Massachusetts Institute of Technology (MIT).
BioCentriq and Kytopen Enter Cell Therapy Partnership contractpharma
March 24, 2021
BioCentriq, the New Jersey Innovation Institute’s cell and gene therapy development and manufacturing center, has entered a partnership with Kytopen, a Cambridge, MA-based startup spun out of Massachusetts Institute of Technology (MIT).
Tevogen Bio, BioCentriq Partner for COVID T-cell Therapy contractpharma
March 17, 2021
Tevogen Bio has entered a partnership with BioCentriq, a New Jersey based cell and gene therapy development and manufacturing center, to support clinical manufacturing of Tevogen’s investigational COVID-19 treatment.
NJII Launches BioCentriq Cell & Gene Therapy Mfg. Center contractpharma
May 07, 2020
Process development and clinical manufacturing facility for cell and gene therapies becomes first of its kind located on a U.S. university campus.